Harlow John B. Jr.
SEC insider (Form 3/4/5 filer). CIK 0002095554. President and COO at Larimar Therapeutics, Inc. (LRMR) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 29, 2026. Located in BALA CYNWYD, PA.
Companies Harlow John B. Jr. has filed insider reports for
- Larimar Therapeutics, Inc. (LRMR): Officer, President and COO
- Esperion Therapeutics, Inc. (ESPR): Officer, Chief Commercial Officer
Harlow John B. Jr.
CIK: 0002095554
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
